ALEXANDRIA, Va., June 9 -- United States Patent no. 12,286,422, issued on April 29, was assigned to University of Utah Research Foundation (Salt Lake City).
"Methods and compositions of 4-substituted benzoylpiperazine-1-substituted carbonyls as Beta-catenin/B-cell lymphoma 9 inhibitors" was invented by Haitao Ji (Salt Lake City) and Min Zhang (Salt Lake City).
According to the abstract* released by the U.S. Patent & Trademark Office: "In one aspect, the invention relates to 4-substituted benzoylpiperazine-1-substituted carbonyls having a structure represented by a formula:derivatives thereof, and related compounds; synthetic methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of treating dis...